Skip to content
10-Q

Quarterly Report

OnKure Therapeutics, Inc. OKUR

0001193125-25-269540

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 13.53M sh
Shares Diluted Q3 2025 · Sep 30, 2025 13.49M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 316.14K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 315.22K sh
Capex Q3 2025 · Sep 30, 2025 $37K
Capex restated Q3 2025 · Sep 30, 2024 $37K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$40.32M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$27.76M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $70.33M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $110.76M
Stockholders Equity Q3 2025 · Sep 30, 2025 $66.43M
Stockholders Equity Q3 2025 · Jun 30, 2025 $78.17M
Stockholders Equity Q3 2025 · Mar 31, 2025 $90.65M
Stockholders Equity Q3 2025 · Dec 31, 2024 $103.83M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$135.05M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$123.58M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 −$111.26M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$101.84M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.25M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.53M
Total Liabilities Q3 2025 · Sep 30, 2025 $6.41M
Total Liabilities Q3 2025 · Dec 31, 2024 $11.08M
Current Assets Q3 2025 · Sep 30, 2025 $71.53M
Current Assets Q3 2025 · Dec 31, 2024 $113M
Total Assets Q3 2025 · Sep 30, 2025 $72.84M
Total Assets Q3 2025 · Dec 31, 2024 $114.91M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.09
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.41
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$36.55
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$111.77
Eps Basic Q3 2025 · Sep 30, 2025 −$1.09
Eps Basic Q3 2025 · Sep 30, 2025 −$3.41
Eps Basic restated Q3 2025 · Sep 30, 2024 −$36.55
Eps Basic restated Q3 2025 · Sep 30, 2024 −$111.77
Sga Expense Q3 2025 · Sep 30, 2025 $3.59M
Sga Expense Q3 2025 · Sep 30, 2025 $11.29M
Sga Expense restated Q3 2025 · Sep 30, 2024 $1.4M
Sga Expense restated Q3 2025 · Sep 30, 2024 $6.25M
Rd Expense Q3 2025 · Sep 30, 2025 $11.92M
Rd Expense Q3 2025 · Sep 30, 2025 $37.54M
Rd Expense restated Q3 2025 · Sep 30, 2024 $10.12M
Rd Expense restated Q3 2025 · Sep 30, 2024 $29.43M
Net Income Q3 2025 · Sep 30, 2025 −$14.7M
Net Income Q3 2025 · Sep 30, 2025 −$46.01M
Net Income Q3 2025 · Jun 30, 2025 −$15.39M
Net Income Q3 2025 · Mar 31, 2025 −$15.93M
Net Income Q3 2025 · Dec 31, 2024 −$17.44M
Net Income restated Q3 2025 · Sep 30, 2024 −$11.56M
Net Income restated Q3 2025 · Sep 30, 2024 −$35.23M
Net Income restated Q3 2025 · Jun 30, 2024 −$14.14M
Net Income restated Q3 2025 · Mar 31, 2024 −$9.54M
Operating Income Q3 2025 · Sep 30, 2025 −$15.5M
Operating Income Q3 2025 · Sep 30, 2025 −$48.83M
Operating Income restated Q3 2025 · Sep 30, 2024 −$11.51M
Operating Income restated Q3 2025 · Sep 30, 2024 −$35.69M